Deferoxamine interference in fibro-inflammation: additional action in control of obese adipose tissue dysfunction.

Erica Martins Ferreira GotardoThaina Rodrigues de MoraisAna Paula Timóteo FerreiraCintia Rabelo E Paiva CariaMarcelo Lima RibeiroAlessandra Gambero

Published in: Current drug targets (2023)

Deferoxamine could be an alternative to control fibro-inflammation in obese adipose tissue, contributing to the metabolic improvements previously described.

Keyphrases

adipose tissue
oxidative stress
insulin resistance
high fat diet
metabolic syndrome
weight loss
type diabetes
skeletal muscle